Nilsine Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.06M Buy
23,855
+187
+0.8% +$43.6K 0.42% 59
2026
Q1
$5.33M Buy
23,668
+1,829
+8% +$426K 0.42% 60
2025
Q4
$4.52M Buy
21,839
+258
+1% +$51K 0.39% 55
2025
Q3
$4M Buy
21,581
+1,082
+5% +$185K 0.36% 60
2025
Q2
$3.13M Sell
20,499
-357
-2% -$54.9K 0.32% 76
2025
Q1
$3.46M Sell
20,856
-13
-0.1% -$2.03K 0.38% 61
2024
Q4
$3.02M Buy
20,869
+2,787
+15% +$432K 0.32% 71
2024
Q3
$2.93M Sell
18,082
-54
-0.3% -$8.6K 0.38% 64
2024
Q2
$2.65M Sell
18,136
-931
-5% -$138K 0.36% 70
2024
Q1
$3.02M Sell
19,067
-103
-0.5% -$16.4K 0.41% 64
2023
Q4
$3M Sell
19,170
-2,422
-11% -$371K 0.46% 64
2023
Q3
$3.36M Sell
21,592
-530
-2% -$87.5K 0.51% 58
2023
Q2
$3.66M Buy
22,122
+359
+2% +$57.9K 0.54% 58
2023
Q1
$3.37M Buy
+21,763
New +$3.51M 0.53% 53

Other funds holding JNJ

Nilsine Partners's JNJ Position: Q2 2026 in Review

Nilsine Partners increased its Johnson & Johnson (JNJ) stake by 0.79% in Q2 2026, buying an estimated $43.6K and bringing the position to 23,855 shares worth $6.06M. The position accounts for 0.42% of the portfolio, ranked #59.

Nilsine Partners first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nilsine Partners held 23,855 shares of Johnson & Johnson worth $6.06M as of Q2 2026.
  • Nilsine Partners bought 187 Johnson & Johnson shares in Q2 2026, an estimated $43.6K.
  • Johnson & Johnson made up 0.42% of Nilsine Partners's portfolio in Q2 2026, its #59 holding.
  • Nilsine Partners first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.